Xeris Biopharma Holdings Inc (XERS)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-03 | Ms. Marla S. PerskyIndependent Chairman | -15.50k | 91.43k | Automatic Disposition | 5.90 | 132.87k | -10.45% |
| 2026-06-04 | Ms. Dawn HalkuffIndependent Director | -20.00k | 121.89k | Automatic Disposition | 6.09 | 100.41k | -16.61% |
| 2026-06-04 | Dr. Barbar-Jean Anne Bormann-KennedyIndependent Director | -16.00k | 97.51k | Automatic Disposition | 6.09 | 126.50k | -11.23% |
| 2026-06-04 | Mr. John H. JohnsonIndependent Non-Executive Director | -15.00k | 91.42k | Automatic Disposition | 6.09 | 683.08k | -2.15% |
| 2026-06-01 | Ms. Beth P. HechtChief Legal Officer & Corporate Secretary | -16.67k | 100.98k | Automatic Disposition | 6.06 | 681.88k | -2.39% |
| 2026-05-01 | Ms. Beth P. HechtChief Legal Officer & Corporate Secretary | -16.67k | 103.81k | 売り | 6.23 | 698.55k | -2.33% |
| 2026-04-01 | Ms. Beth P. HechtChief Legal Officer & Corporate Secretary | -16.67k | 99.86k | Automatic Disposition | 5.99 | 715.21k | -2.28% |
| 2026-03-30 | Mr. James Aloysius BradyIndependent Director | -10.83k | 60.04k | Automatic Disposition | 5.54 | 89.17k | -10.83% |
| 2026-03-12 | Mr. Kevin McCullochPresident & COO | 48.90k | 199.99k | Derivative Exercise and Retained Stock | 3.94 - 4.09 | 1.80M | 2.79% |
| 2026-03-05 | Mr. Steven M. PieperCFO | 41.93k | 197.31k | Derivative Exercise and Retained Stock | 4.09 - 5.93 | 1.41M | 3.07% |
| 2026-03-02 | Ms. Beth P. HechtChief Legal Officer & Corporate Secretary | -16.67k | 104.09k | Automatic Disposition | 6.24 - 7.06 | 731.88k | -2.23% |
| 2026-02-24 | Dr. Anh T. NguyenChief Medical Officer | -29.30k | 201.58k | Sale to Issuer | 6.88 | 80.94k | -26.58% |
| 2026-01-31 | Mr. Kevin McCullochPresident & COO | -126.06k | 927.82k | Sale to Issuer | 7.36 | 1.75M | -6.71% |
| 2026-01-31 | Mr. John P. ShannonCEO & Director | -340.51k | 2.51M | Sale to Issuer | 7.36 | 1.51M | -18.43% |
| 2026-01-31 | Mr. Steven M. PieperCFO | -205.53k | 1.51M | Sale to Issuer | 7.36 | 1.37M | -13.07% |
| 2026-02-02 | Ms. Beth P. HechtChief Legal Officer & Corporate Secretary | -16.67k | 124.15k | Automatic Disposition | 7.45 | 748.55k | -2.18% |
| 2026-01-31 | Ms. Beth P. HechtChief Legal Officer & Corporate Secretary | -169.56k | 1.25M | Sale to Issuer | 7.36 | 748.55k | -18.47% |
| 2026-01-08 | Mr. Kevin McCullochPresident & COO | -15.00k | 120.00k | Automatic Disposition | 8.00 | 1.71M | -0.87% |
| 2026-01-05 | Mr. John P. ShannonCEO & Director | 92.30k | 150.00k | Derivative Exercise and Retained Stock | 1.55 - 3.94 | 1.08M | 9.34% |
| 2026-01-05 | Mr. John P. ShannonCEO & Director | -24.91k | 176.26k | Automatic Disposition | 7.08 | 1.08M | -2.25% |
| 2026-01-02 | Ms. Beth P. HechtChief Legal Officer & Corporate Secretary | -16.67k | 123.78k | Automatic Disposition | 7.43 | 506.44k | -3.19% |
| 2025-12-19 | Mr. John H. JohnsonIndependent Non-Executive Director | -135.40k | 977.02k | 売り | 7.22 | 648.08k | -17.28% |
| 2025-12-12 | Dr. Barbar-Jean Anne Bormann-KennedyIndependent Director | -15.00k | 106.41k | Automatic Disposition | 7.09 | 92.50k | -13.95% |
| 2025-12-01 | Ms. Beth P. HechtChief Legal Officer & Corporate Secretary | -16.67k | 116.78k | Automatic Disposition | 7.01 | 518.51k | -3.11% |
| 2025-11-14 | Mr. John P. ShannonCEO & Director | 87.10k | 135.01k | Derivative Exercise and Retained Stock | 1.55 | 1.01M | 9.40% |
| 2025-11-13 | Mr. John P. ShannonCEO & Director | -8.97k | 53.02k | Derivative Exercise and Sale | 1.55 - 7.46 | 1.01M | - |
| 2025-11-13 | Mr. John P. ShannonCEO & Director | -14.27k | 106.48k | Automatic Disposition | 7.46 | 1.01M | -1.39% |
| 2025-11-11 | Ms. Beth P. HechtChief Legal Officer & Corporate Secretary | -16.67k | 123.30k | Automatic Disposition | 7.40 | 535.18k | -3.02% |
| 2025-10-02 | Mr. Kevin McCullochPresident & COO | -733.00 | 6.09k | Sale to Issuer | 8.31 | 1.73M | -0.04% |
| 2025-09-11 | Mr. Kevin McCullochPresident & COO | -2.00k | 0.00 | Other Disposition | - | 1.73M | -0.12% |
| 2025-09-11 | Ms. Marla S. PerskyIndependent Chairman | -15.50k | 119.61k | Automatic Disposition | 7.72 | 98.37k | -13.61% |
| 2025-08-28 | Dr. Jeffrey W. Shermanインサイダー | 4.81k | 32.02k | Derivative Exercise and Retained Stock | 6.66 | 174.59k | 2.83% |
| 2025-08-28 | Dr. Jeffrey W. Shermanインサイダー | -42.23k | 53.25k | Derivative Exercise and Sale | 6.66 - 7.92 | 174.59k | - |
| 2025-08-13 | Mr. John H. JohnsonIndependent Non-Executive Director | -107.50k | 786.46k | 売り | 7.32 | 783.48k | -12.07% |
| 2025-08-12 | Ms. Dawn HalkuffIndependent Director | -42.50k | 309.23k | 売り | 7.28 | 70.41k | -37.64% |
| 2025-08-01 | Mr. Kevin McCullochPresident & COO | -14.65k | 78.82k | Sale to Issuer | 5.38 | 1.73M | -0.84% |
| 2025-08-01 | Mr. John P. ShannonCEO & Director | -36.92k | 198.62k | Sale to Issuer | 5.38 | 940.76k | -3.78% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。